Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry

Neurology and Therapy ◽

10.1007/s40120-021-00320-w ◽

2022 ◽

Author(s):

Niklas Frahm ◽

Firas Fneish ◽

David Ellenberger ◽

Peter Flachenecker ◽

Friedemann Paul ◽

...

Keyword(s):

Multiple Sclerosis ◽

Long Term Experience

Download Full-text

Long-term experience with current disease-modifying drugs in multiple sclerosis

Journal of Neurology ◽

10.1007/s00415-006-6007-6 ◽

2006 ◽

Vol 253 (S6) ◽

pp. vi37-vi44 ◽

Cited By ~ 1

Author(s):

Corey C. Ford

Keyword(s):

Multiple Sclerosis ◽

Disease Modifying Drugs ◽

Disease Modifying ◽

Long Term Experience

Download Full-text

PO10-TU-50 Hungarian long term experience of natalizumab in multiple sclerosis patients from clinical trials

Journal of the Neurological Sciences ◽

10.1016/s0022-510x(09)70799-3 ◽

2009 ◽

Vol 285 ◽

pp. S209

Author(s):

T. Csepany ◽

J. Sikula ◽

G. Jakab ◽

A. Guseo ◽

G. Rum ◽

...

Keyword(s):

Multiple Sclerosis ◽

Clinical Trials ◽

Multiple Sclerosis Patients ◽

Long Term Experience

Download Full-text

Fingolimod in the treatment of relapsing–remitting multiple sclerosis: long-term experience and an update on the clinical evidence

Therapeutic Advances in Neurological Disorders ◽

10.1177/1756285616628766 ◽

2016 ◽

Vol 9 (2) ◽

pp. 130-147 ◽

Cited By ~ 39

Author(s):

Bhupendra O. Khatri

Keyword(s):

Multiple Sclerosis ◽

Clinical Evidence ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis ◽

Long Term Experience

Download Full-text

Long-term experience with induction treatment regimens in multiple sclerosis

Journal of the Neurological Sciences ◽

10.1016/s0022-510x(09)70013-9 ◽

2009 ◽

Vol 277 ◽

pp. S46-S49 ◽

Cited By ~ 16

Author(s):

Emmanuelle Le Page ◽

Gilles Edan

Keyword(s):

Multiple Sclerosis ◽

Induction Treatment ◽

Treatment Regimens ◽

Long Term Experience

Download Full-text

Long-term experience with Natalizumab as first-line treatment for highly active pediatric multiple sclerosis: A case report

10.26226/morressier.59a3e8b6d462b8028d8954e4 ◽

2017 ◽

Author(s):

Smail Daoudi

Keyword(s):

Multiple Sclerosis ◽

Case Report ◽

Line Treatment ◽

First Line ◽

Pediatric Multiple Sclerosis ◽

Highly Active ◽

Long Term Experience ◽

First Line Treatment

Download Full-text

Long-term experience with interferon beta-1b (Betaferon®) in multiple sclerosis

Journal of Neurology ◽

10.1007/s00415-005-2014-2 ◽

2005 ◽

Vol 252 (S3) ◽

pp. iii28-iii33 ◽

Cited By ~ 10

Author(s):

Barry G. W. Arnason

Keyword(s):

Multiple Sclerosis ◽

Interferon Beta ◽

Long Term Experience

Download Full-text

842: Low Efficacy of Intravesical BCG Immunotherapy in Elderly Patients with Intermediate-High Risk Ta-T1 Transitional Cell Carcinoma (TCC) of the Bladder: Long Term Experience of a Single Institution

The Journal of Urology ◽

10.1016/s0022-5347(18)33078-7 ◽

2006 ◽

Vol 175 (4S) ◽

pp. 271-272 ◽

Cited By ~ 1

Author(s):

Giorgio Verrini ◽

Maurizio Brausi ◽

Mirko Gavioli ◽

Giuseppe De Luca ◽

Giancarlo Peracchia ◽

...

Keyword(s):

High Risk ◽

Elderly Patients ◽

Transitional Cell Carcinoma ◽

Cell Carcinoma ◽

Transitional Cell ◽

Single Institution ◽

Bcg Immunotherapy ◽

Intravesical Bcg ◽

Long Term Experience

Download Full-text

Long Term Experience with Seawalls on an Exposed Coast

Coastal Engineering 1988 ◽

10.1061/9780872626874.183 ◽

1989 ◽

Author(s):

Orville T. Magoon ◽

Joan L. Pope ◽

Robert L. Sloan ◽

Donald D. Treadwell

Keyword(s):

Long Term Experience

Download Full-text

Long-Term Lymphocyte Counts in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) Treated with Cladribine Tablets 3.5 mg/kg: Total Lymphocytes, B and T Cell Subsets

10.26226/morressier.59a3eda8d462b8028d8950f6 ◽

2017 ◽

Cited By ~ 3

Author(s):

Per Soelberg-Sorensen

Keyword(s):

Multiple Sclerosis ◽

T Cell ◽

T Cell Subsets ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Benign multiple sclerosis: does the initial outcome predict a favorable long term evolution?

10.26226/morressier.59a3edaad462b8028d894294 ◽

2017 ◽

Author(s):

Elisabet Matas

Keyword(s):

Multiple Sclerosis ◽

Long Term Evolution ◽

Term Evolution ◽

Initial Outcome ◽

Benign Multiple Sclerosis

Download Full-text